Abstract
Cancer patients have an increased risk of infectious complications, the main cause of which is an immunodeficiency condition caused by the cancer itself and its therapy. Therefore, it is appropriate to protect patients by vaccination, in particular vaccination against influenza, pneumococcal infections and covid-19.
Appropriately chosen vaccines and the right timing of their administration can as a part of supportive care contribute to the success of cancer therapy.